Johann S. De Bono

ORCID: 0000-0002-2034-595X

Also affiliated with Institute of Cancer Research, Cancer Research UK, Institute of Cancer Research, Royal Marsden Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

21.4Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive genomic characterization of squamous cell lung cancers

Nature(2012)10.1038/nature11404

Top 1%

11.0DataRank

Top 1%4036 citations

Gad Getz, Stephen E. Schumacher, Petar Stojanov, Chang‐Jiun Wu, Hailei Zhang +326 more

Papers

Driven by 43 papers — median percentile 97. Top paper: “Comprehensive genomic characterization of squamous cell lung cancers”.

Comprehensive genomic characterization of squamous cell lung cancers

Nature(2012)10.1038/nature11404

Top 1%

11.0DataRank

Top 1%4036 citations

Gad Getz, Stephen E. Schumacher, Petar Stojanov, Chang‐Jiun Wu, Hailei Zhang +326 more

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

The Lancet(2024)10.1016/s0140-6736(24)01653-2

N/A

4.3DataRank · unranked

287 citations

Daniel Castellano, Ken Herrmann, Johann S. De Bono, Neal D. Shore, Kim N. +18 more

RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1114

N/A

2.7DataRank · unranked

99 citations

Wei Yuan, Kexin Xu, Peter Gallagher, Angel Pang, Yi Fang Guan +20 more

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International Journal of Cancer(2021)10.1002/ijc.33861

N/A

1.9DataRank · unranked

62 citations

Jean‐Yves Blay, Irene García, Johann S. De Bono, Christophe Le Tourneau, Víctor Moreno +25 more

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers

New England Journal of Medicine(2009)10.1056/nejmoa0900212

N/A

1.2DataRank · unranked

3622 citations

David S. Boss, Timothy A. Yap, Richard Turkington, Peijun Wu, Marja Mergui-Roelvink +14 more

Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3023

N/A

0.672DataRank · unranked

87 citations

Rendong Yang, Christine Henzler, Yeung Ho, Courtney N. Passow, Benjamin Auch +14 more

Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

Annals of Oncology(2025)10.1016/j.annonc.2025.07.003

N/A

0.663DataRank · unranked

31 citations

K.N. Chi, Neal D. Shore, Ken Herrmann, Johann S. De Bono, Daniel Castellano +88 more

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Oncogene(2023)10.1038/s41388-023-02604-x

N/A

0.650DataRank · unranked

75 citations

Kirsty Hodgson, Beatriz de la Calle, Helen Turner, Kathleen Cheung, Abel Bermudez +54 more

The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1090

N/A

0.589DataRank · unranked

10 citations

Karim Fizazi, Fred Saad, Kim N. Chi, Mary-Ellen Taplin, Cora N. Sternberg +5 more

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2409

N/A

0.578DataRank · unranked

46 citations

Anthony W. Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking +6 more

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol

BMJ Open(2023)10.1136/bmjopen-2022-068173

N/A

0.529DataRank · unranked

33 citations

Olga Solovyeva, Munyaradzi Dimairo, Christopher J. Weir, Thomas Jaki, Adrian Mander +11 more

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0851

N/A

0.529DataRank · unranked

33 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02661

N/A

0.510DataRank · unranked

29 citations

Qian Yang, Akash Roy, Bin Luo, John C. Araujo, Christopher J. Logothetis +15 more

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study

BMC Medicine(2023)10.1186/s12916-023-02937-0

N/A

0.497DataRank · unranked

12 citations

Munyaradzi Dimairo, Christopher J. Weir, Siew Wan Hee, Aude Espinasse, Moreno Ursino +18 more

NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.18.549585

N/A

0.420DataRank · unranked

8 citations

Alessandro Vasciaveo, D Karagiannis, Zhen Sun, Xiao CHEN, Fabio Socciarelli +15 more

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress

Nature Communications(2025)10.1038/s41467-025-60238-x

N/A

0.417DataRank · unranked

12 citations

Keshan Wang, Mannan Nouri, N. V. Kozlova, Daniel R. Schmidt, Anastasia Stavridi +27 more

SARS-CoV-2 vaccination and phase 1 cancer clinical trials

The Lancet Oncology(2021)10.1016/s1470-2045(21)00017-6

N/A

0.385DataRank · unranked

12 citations

Lillian L. Siu, Emiliano Calvo, Martijn P. Lolkema, Patricia LoRusso, Jean‐Charles Soria +5 more

Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects

JCO Precision Oncology(2024)10.1200/po.23.00441

N/A

0.312DataRank · unranked

7 citations

Adrian P. Mander, Johann S. De Bono, Haiyan Zheng, Christina Yap, Zhulin Yin

Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1500

N/A

0.312DataRank · unranked

7 citations

David S.P. Tan, Anastasios Stathis, Geoffrey I. Shapiro, Satoru Iwasa, Markus Joerger +17 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0.292DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

medRxiv(2022)10.1101/2022.03.10.22271799

N/A

0.165DataRank · unranked

2 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer

iScience(2025)10.1016/j.isci.2025.113985

N/A

0.104DataRank · unranked

1 citations

Juan M. Jiménez-Vacas, Ines Figueiredo, Jonathan Welti, Bora Gurel, Denisa Bogdan +22 more

Critical role of antioxidant programs in enzalutamide-resistant prostate cancer

Oncogene(2023)10.1038/s41388-023-02756-w

N/A

0DataRank · unranked

13 citations

Karla Parra, Antje Neeb, Lorenzo Buroni, Denisa Bogdan, Wei Yuan +9 more

27-hydroxycholesterol and DNA damage repair: implication in prostate cancer

Frontiers in Oncology(2023)10.3389/fonc.2023.1251297

N/A

0DataRank · unranked

7 citations

Nadine A. Friedrich, Sanjay Das, James P. Daniels, Sara Pollan, Shweta Dambal +12 more

Targeting radioresistance and replication fork stability in prostate cancer

JCI Insight(2022)10.1172/jci.insight.152955

N/A

0DataRank · unranked

9 citations

GuemHee Baek, Suzanne Carreira, Wei Yuan, Shihong Ma, Mia Hofstad +12 more

H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2114324119

N/A

0DataRank · unranked

50 citations

Ritika Tiwari, Sirvan Khalighi, Ankur Chakravarthy, Wei Yuan, Michael Berk +12 more

Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.15.567243

N/A

0DataRank · unranked

2 citations

Emily L. Symons, Lorenzo Buroni, Hiruni K. Sumanisiri, Jessica Andrew-Udoh, Emily Witt +7 more

Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

(2023)10.1158/1078-0432.c.6532445

N/A

0DataRank · unranked

0 citations

Ines Figueiredo, Rosina T. Lis, Ilsa M. Coleman, Bora Gurel, Denisa Bogdan +26 more

Development process of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE (DosE FIndiNg Extensions) study

MetArXiv (OSF Preprints)(2023)10.31222/osf.io/jtpz2

N/A

0DataRank · unranked

0 citations

Munyaradzi Dimairo, Christopher J. Weir, Siew Wan Hee, Moreno Ursino, Aude Espinasse +18 more

Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-1159

N/A

0DataRank · unranked

20 citations

Ayesha A. Shafi, Jennifer J. McCann, Wei Yuan, Talya S. Laufer, Denisa Bogdan +9 more

HER3 Is an Actionable Target in Advanced Prostate Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-3360

N/A

0DataRank · unranked

69 citations

Susana Miranda, Ruth Riisnaes, Bora Gurel, Mariantonietta D’Ambrosio, Alessandro Vasciaveo +40 more

Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102862

N/A

0DataRank · unranked

26 citations

Andrei Gafita, Johann S. De Bono, Oliver Sartor, Kim N., Bernd J. Krause +11 more

Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer

Journal of Visualized Experiments(2024)10.3791/66072

N/A

0DataRank · unranked

4 citations

Emily L. Symons, Lorenzo Buroni, Hiruni K. Sumanasiri, Jessica Andrew-Udoh, Emily Witt +7 more

77P Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

ESMO Open(2024)10.1016/j.esmoop.2024.103818

N/A

0DataRank · unranked

0 citations

D. Westaby, Ines Figueiredo, A. De Haven Brandon, Ana Padilha, W. Yuan +15 more

Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study

UNC Libraries(2020)10.17615/yxdm-6w50

N/A

0DataRank · unranked

0 citations

Christopher J. Sweeney, Frauke Schimmöller, Dana E. Rathkopf, Naomi B. Haas, Celestia S. Higano +16 more

AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification

Cancer Treatment and Research Communications(2020)10.1016/j.ctarc.2020.100218

N/A

0DataRank · unranked

3 citations

Adam Sharp, Shana Y. Trostel, Johann S. De Bono, Stephen R. Plymate, Adam G. Sowalsky

The landscape of RNA polymerase II–associated chromatin interactions in prostate cancer

Journal of Clinical Investigation(2020)10.1172/jci134260

N/A

0DataRank · unranked

62 citations

Yong Chen, Jiapei Yuan, Kelly Daescu, Maryou Lambros, Kathleen E. Houlahan +17 more

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma

Journal of Clinical Investigation(2020)10.1172/jci134132

N/A

0DataRank · unranked

71 citations

Tong Liang, Yann Jamin, Susanne Walz, Colin Kwok, Anne Hakkert +38 more

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Research Square(2022)10.21203/rs.3.rs-2092111/v1

N/A

0DataRank · unranked

1 citations

Emma Scott, Kirsty Hodgson, Beatriz de la Calle, Helen Turner, Kathleen Cheung +54 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

Johann S. De Bono

Indexed papers

Top data-sharing exemplar

Papers